Arrowhead Pharmaceuticals Inc. buy Morgan Stanley
Start price
21.04.26
/
50%
€61.38
Target price
21.04.27
€84.90
Performance (%)
4.40%
Price
08.06.26
€64.08
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 4.40%. This prediction currently runs until 21.04.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -0.836% | -0.836% |
| iShares Core DAX® | -2.195% | 0.670% |
| iShares Nasdaq 100 | -2.629% | 2.992% |
| iShares Nikkei 225® | -2.021% | 3.141% |
| iShares S&P 500 | -1.670% | 2.405% |
Comments by Morgan_Stanley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (ARWR) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $100.00 price target on the stock, up from $78.00.
Ratings data for ARWR provided by MarketBeat